What does IBDQ stand for?

The recruited 40 patients--20 in each treatment group, were evaluated with the help of a Crohn's Disease Activity Index (CDAI) questionnaire, an Inflammatory Bowel Disease Questionnaire (IBDQ), the 21-item Hamilton Depression Scale (HAMD) and an 8-item Visual Analogue Scale (VA-Scale) in 2-week intervals during the first 10 study weeks, and then at week 12, 16 and 20, which were the trial-medication free observation periods.

Quality of life was assessed by the Inflammatory Bowel Disease Questionnaire (IBDQ), an evaluation of health perception and function, completed by each subject before and at the end of treatment.

The subjects were monitored for Crohn's Disease Activity Index (CDAI), Inflammatory Bowel Disease Questionnaire (IBDQ) and a number of potential surrogate biomarkers.

This analysis explored the impact of REMICADE treatment on four pain independent questions (one in each of the CDAI and Inflammatory Bowel Disease Questionnaire (IBDQ), and two in the SF-36), which were compared between the single-dose (5mg/kg IV at week 0) and the 3-dose (5mg/kg at weeks 0, 2 and 6) REMICADE induction regimens.

Quality of life was assessed by the Inflammatory Bowel Disease Questionnaire (IBDQ), an evaluation of health perception and function, completed by each subject before and at the end of treatment.

Quality of life was assessed by the Inflammatory Bowel Disease Questionnaire (IBDQ), an evaluation of health perception and function, completed by each subject before and at the end of treatment.